126 related articles for article (PubMed ID: 32666378)
21. First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma.
Wen PY; Cloughesy TF; Olivero AG; Morrissey KM; Wilson TR; Lu X; Mueller LU; Coimbra AF; Ellingson BM; Gerstner E; Lee EQ; Rodon J
Clin Cancer Res; 2020 Apr; 26(8):1820-1828. PubMed ID: 31937616
[TBL] [Abstract][Full Text] [Related]
22. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
Rajkumar SV; Buckner JC; Schomberg PJ; Reid JM; Bagniewski PJ; Ames MM; Cascino TL; Marks RS
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):969-75. PubMed ID: 9869217
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients.
Silvani A; Eoli M; Salmaggi A; Lamperti E; Maccagnano E; Broggi G; Boiardi A
J Neurooncol; 2004 Jan; 66(1-2):203-8. PubMed ID: 15015788
[TBL] [Abstract][Full Text] [Related]
24. Direct delivery of medication into a brain tumor through multiple chronically implanted catheters.
Bouvier G; Penn RD; Kroin JS; Beique R; Guerard MJ
Neurosurgery; 1987 Feb; 20(2):286-91. PubMed ID: 3031539
[TBL] [Abstract][Full Text] [Related]
25. Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas.
van den Bent MJ; Schellens JH; Vecht CJ; Sillevis Smit PA; Loosveld OJ; Ma J; Tijssen CC; Jansen RL; Kros JM; Verweij J
Eur J Cancer; 1998 Sep; 34(10):1570-4. PubMed ID: 9893630
[TBL] [Abstract][Full Text] [Related]
26. [A case of recurrent malignant glioma treated by superselective intraarterial chemotherapy with a combination of etoposide and cisplatin].
Nakagawa H; Kubo S; Fujita T; Tsuruzono K; Miyawaki Y; Arita N; Hayakawa T
Gan To Kagaku Ryoho; 1992 Feb; 19(2):237-40. PubMed ID: 1736836
[TBL] [Abstract][Full Text] [Related]
27. Intracerebral microdialysis in neurosurgical intensive care patients utilising catheters with different molecular cut-off (20 and 100 kD).
Hillman J; Milos P; Yu ZQ; Sjögren F; Anderson C; Mellergård P
Acta Neurochir (Wien); 2006 Mar; 148(3):319-24; discussion 324. PubMed ID: 16411015
[TBL] [Abstract][Full Text] [Related]
28. The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor.
Straathof CS; van den Bent MJ; Ma J; Schmitz PI; Kros JM; Stoter G; Vecht CJ; Schellens JH
J Neurooncol; 1998 Mar; 37(1):1-8. PubMed ID: 9525832
[TBL] [Abstract][Full Text] [Related]
29. Cerebral microdialysis monitoring: determination of normal and ischemic cerebral metabolisms in patients with aneurysmal subarachnoid hemorrhage.
Schulz MK; Wang LP; Tange M; Bjerre P
J Neurosurg; 2000 Nov; 93(5):808-14. PubMed ID: 11059662
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of cisplatin and synchrotron irradiation on F98 gliomas growing in nude mice.
Ricard C; Fernandez M; Requardt H; Wion D; Vial JC; Segebarth C; van der Sanden B
J Synchrotron Radiat; 2013 Sep; 20(Pt 5):777-84. PubMed ID: 23955042
[TBL] [Abstract][Full Text] [Related]
31. Intratumoral microinfusion of nimustine (ACNU) for recurrent glioma.
Wakabayashi T; Yoshida J; Mizuno M; Kajita Y
Brain Tumor Pathol; 2001; 18(1):23-8. PubMed ID: 11517970
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of weekly docetaxel and cisplatin in patients with advanced recurrent and metastatic head and neck cancer.
Guntinas-Lichius O; Appenrodt S; Veelken F; Krug B
Laryngoscope; 2006 Apr; 116(4):613-8. PubMed ID: 16585868
[TBL] [Abstract][Full Text] [Related]
33. A neuropharmacokinetic assessment of bafetinib, a second generation dual BCR-Abl/Lyn tyrosine kinase inhibitor, in patients with recurrent high-grade gliomas.
Portnow J; Badie B; Markel S; Liu A; D'Apuzzo M; Frankel P; Jandial R; Synold TW
Eur J Cancer; 2013 May; 49(7):1634-40. PubMed ID: 23380277
[TBL] [Abstract][Full Text] [Related]
34. Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hematology.
Wagner S; Erdlenbruch B; Längler A; Gnekow A; Kühl J; Albani M; Völpel S; Bucsky P; Emser A; Peters O; Wolff JE
Cancer; 2004 Apr; 100(8):1750-7. PubMed ID: 15073866
[TBL] [Abstract][Full Text] [Related]
35. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
[TBL] [Abstract][Full Text] [Related]
36. Concurrent cisplatin therapy and iodine 125 brachytherapy for recurrent malignant brain tumors.
Chamberlain MC; Barba D; Kormanik P; Berson AM; Saunders WM; Shea MC
Arch Neurol; 1995 Feb; 52(2):162-7. PubMed ID: 7848125
[TBL] [Abstract][Full Text] [Related]
37. Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure.
Spence AM; Berger MS; Livingston RB; Ali-Osman F; Griffin B
J Neurooncol; 1992 Feb; 12(2):187-91. PubMed ID: 1560266
[TBL] [Abstract][Full Text] [Related]
38. Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study.
Hau P; Kunz-Schughart L; Bogdahn U; Baumgart U; Hirschmann B; Weimann E; Muhleisen H; Ruemmele P; Steinbrecher A; Reichle A
Oncology; 2007; 73(1-2):21-5. PubMed ID: 18332649
[TBL] [Abstract][Full Text] [Related]
39. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
[TBL] [Abstract][Full Text] [Related]
40. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response.
Pace A; Vidiri A; Galiè E; Carosi M; Telera S; Cianciulli AM; Canalini P; Giannarelli D; Jandolo B; Carapella CM
Ann Oncol; 2003 Dec; 14(12):1722-6. PubMed ID: 14630675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
